Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel low-temperature route for erlotinib intermediates eliminates noble metals. Reduces costs and improves supply chain stability for API manufacturing.
Patent CN108101841B details a controlled hydrogenation method for Indacaterol, significantly reducing Impurity A and enhancing manufacturing efficiency for global supply chains.
Patent CN111349014A reveals a safer, high-yield route for Methyl (methylamino)squarate, eliminating hazardous solvents and reducing manufacturing costs for global supply chains.
Novel convergent route for Gefitinib intermediates eliminating chromatography. High yield, scalable process for pharmaceutical manufacturing supply chains.
Patent CN110143973B reveals a novel inorganic salt salification process for Flomoxef Sodium, eliminating organic acid residues and ensuring superior stability for pharmaceutical manufacturing.
Patent CN117263941B reveals a novel EGFR inhibitor synthesis with high purity and atom economy. Discover cost reduction and supply chain advantages for pharmaceutical manufacturing.
Novel patent CN120842228A offers high-yield synthesis for HIV and JAK inhibitor intermediates, ensuring cost reduction and supply chain reliability for global manufacturers.
Patent CN106423281A reveals a novel rare earth silamide catalyst for efficient spiro[cyclopropane-1,3'-indole] synthesis, offering mild conditions and cost reduction.
Novel rare earth silamide catalyzed one-pot synthesis for high-purity spiro[cyclopropane-1,3'-indole] intermediates. Cost-effective and scalable pharma manufacturing.
Patent CN110878064A reveals a breakthrough synthesis route for febuxostat impurities, boosting total yield from 0.2% to 43% via strategic intermediate sequencing.
Novel 5-step synthesis from D-Glutamic acid for DPP-IV inhibitors. High yield, mild conditions, and cost-effective industrial manufacturing process.
Patent CN104860926B details a novel preparation method for Vonoprazan fumarate offering high purity and significant cost reduction in pharmaceutical intermediates manufacturing.
Novel patent CN112830879A details a cost-effective Cinacalcet Hydrochloride synthesis using m-trifluoromethyl benzaldehyde, offering significant supply chain and purity advantages.
Advanced synthesis of Nafcillin Sodium Hydrate via optimized ethylation and coupling. Delivers high purity >99.5% and reduced solvent residuals for pharmaceutical manufacturing.
Novel process for Tylvalosin precursor using Tylosin Tartrate. High yield, simplified steps, reduced solvent use. Ideal for veterinary API manufacturing.
Patent CN118125928B reveals a high-purity synthesis route. Achieve significant cost reduction and supply chain reliability for ambroxol intermediates.
Patent CN104926807B details diamine synthesis for Rivaroxaban quality control. Offers cost reduction in API manufacturing and high-purity pharmaceutical intermediates.
Patent CN1101805C reveals a novel amide route for Simvastatin. Eliminate protection steps for cost reduction in API manufacturing and high-purity output.
Discover the novel radical coupling synthesis of octadecanedioic acid (CN112079708A). Achieve >98.5% purity with mild conditions, offering significant cost reduction and supply reliability for polymer applications.
Patent CN112079708A reveals a mild radical coupling route for octadecanedioic acid. Achieve >98.5% purity with reduced costs for polymer and pharma applications.